The Nurse View: Management of Pancreatic Cancer

Slides:



Advertisements
Similar presentations
Our bold approach to life-changing medicines
Advertisements

What would you recommend as first line therapy for a 68 y/o woman with advanced pancreatic cancer and limited metastatic disease with ECOG-1? Gemcitabine.
This house believes that FOLFIRINOX is the best treatment for patients with metastatic pancreatic adenocarcinoma Pro Marc YCHOU Montpellier.
Randomized Phase III Trial Comparing FOLFIRINOX (F: 5FU/Leucovorin [LV], Irinotecan [I], and Oxaliplatin [O]) versus Gemcitabine (G) as First-Line Treatment.
Dr Marco Matos Medical Oncologist Gold Coast Cancer Care, Gold Coast University Hospital and, Pacific Private Oncology Group.
Multimodal Management of Opioid-Induced Constipation
The Patient Experience With Systemic Lupus Erythematosus
What do we do after FOLFIRINOX? Gemcitabine-Based Therapy is Standard
Individualizing Treatment Options in Advanced ER-Positive Breast Cancer.
New Paradigms for HER2-Positive Early Breast Cancer: Implications and Application.
Endocrine Combinations in HR-Positive MBC: The Future Is Now
The Nurse View.
Patient Case 1 Patient Case 1: PET/CT Scan.
Primary Care Challenges in Depression - To Treat or Refer?
NOACs for Cancer-Associated Thrombosis:
An Endocrinology Clinic in Dyslipidemia
Advanced NSCLC Without Actionable Mutations
Tailoring Statin Therapy in Women
Updates in Hodgkin Lymphoma
The Nurse View.
Progression After Cancer Immunotherapy in Advanced NSCLC
The Comprehensive Major Depressive Disorder Care Team
Ask the Onychomycosis Expert, Part 2
Ask the Onychomycosis Expert, Part 1
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Optimizing Outcomes in the Management of GIST
Activity Goals. Activity Goals Discussion Topics.
Clinical Considerations in Evidence-based Management of GIST
Program Goals. The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC.
Decision-making in the eRA of Treating to Target
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.
More Than Meets the Eye.
The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.
Jordan Berlin Co-Director, GI Oncology Program
Program Goals. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer.
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Immunotherapy for cSCC
ADVANCED PARKINSON'S DISEASE:
When Is Biologic Therapy Appropriate for HS?
Advancing Care Across the Spectrum of Pancreatic Cancer
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Patient-Centered Management in Pancreatic Cancer
Traditional Stimulants vs Other Wake-Promoting Agents
Personalizing Management in the Care of Patients With Advanced Sarcoma
Figure 3 Summary of overall survival by Kaplan–Meier
Providing Hope and Opportunity
Locally Advanced Lung Cancer
Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.
Treatment of Locally Advanced Pancreatic Cancer
Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Management of Advanced Pancreatic Adenocarcinoma
Practical Guidance on the Management of Pan-Negative NSCLC
Incorporating Prostacyclins Into Practice
Challenges in LA SCCHN.
Design of the trial. Design of the trial. (1) Patients with advanced recurrent pancreatic cancer aged ≥75 years, (2) unresectable/recurrence, (3) -performance.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Case Studies in Locally Advanced Pancreatic Cancer
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Issues in Patients With Severe Epilepsy
Clinical Considerations in the Use of Checkpoint Inhibitors Breast Cancer.
Clinical Considerations in Evidence-based Management of GIST
Targeting IL-23 for Therapeutic Longevity in Psoriasis
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.
Enthesitis in Psoriatic Arthritis: Disease, Diagnosis and Decisions
Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure
Optimizing Patient Outcomes in Metastatic Triple-Negative Breast Cancer.
Presentation transcript:

The Nurse View: Management of Pancreatic Cancer

Activity Goals

Introduction

Introduction (cont)

Presenting Signs and Symptoms

Diagnosis and Staging

Diagnosis and Surgical Treatment

Treatment of Advanced Disease

Advances in Past 4 Years

Gemcitabine: Standard of Care?

Considerations When Choosing Treatment Options

PRODIGE 4/ACCORD 11 Study: Better Survival With FOLFIRINOX

PRODIGE 4/ACCORD 11: Safety

FOLFIRINOX: Managing Adverse Effects

FOLFIRINOX: Adverse Effects

FOLFIRINOX: Managing Adverse Effects (cont)

Symptom Management: Diarrhea

Why Is Pancreatic Cancer So Hard to Treat?

Nab-paclitaxel Targets the Stroma

MPACT Study: Better Survival With GEM + Nab-Paclitaxel vs GEM Alone

Summary of Overall Survival

Making Treatment Decisions

Comprehensive Care of Patients With Pancreatic Cancer

Coordination of Care

Clinical Trials

Clinical Trial Design

Encourage Clinical Trial Participation

Ongoing Trials

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)